Raia Drogasil (OTCMKTS:RADLY) Releases Earnings Results, Meets Expectations

Raia Drogasil (OTCMKTS:RADLY) posted its quarterly earnings data on Tuesday. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05, Zacks reports.

Raia Drogasil Stock Up 3.3%

Shares of OTCMKTS RADLY traded up $0.12 during mid-day trading on Tuesday, hitting $3.77. The company had a trading volume of 2,842 shares, compared to its average volume of 54,849. Raia Drogasil has a 1-year low of $2.62 and a 1-year high of $5.34. The business’s 50-day simple moving average is $3.56 and its 200 day simple moving average is $4.23.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.